Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q2 2018 · 10-Q
Revenue$154.15M$154.15M+17.0% vs Q2 2017 Net Income$48.85M$48.85M+554.2% vs Q2 2017 EPS Diluted$1.29$1.29+545.0% vs Q2 2017 Gross Profit$101,834,000+15.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$39,182,000−5.2% Free Cash Flowderived$32,847,000−14.7% Margins · derivedGross margin66.1%−0.8 pt vs Q2 2017
Operating margin15.7%+2.1 pt vs Q2 2017
Net margin31.7%+26.0 pt vs Q2 2017
ended Dec 31, 2017 · filed Feb 8, 2018 · 39 d after period end